| Device |
dengue virus antigen assay |
| Regulation Description |
Dengue virus serological reagents. |
| Definition |
Qualitative detection of Dengue virus antigen in human serum or plasma collected from human patients with signs and symptoms consistent with Dengue virus infection |
| Physical State |
ELISA Kit including different components, i.e., ELISA plates coated with antibodies, other capture antibodies, positive and negative controls etc. |
| Technical Method |
Immunoassay e.g., ELISA |
| Target Area |
Human serum or plasma or whole blood or body fluid collected from patient |
| Regulation Medical Specialty |
Microbiology |
| Review Panel |
Microbiology |
| Product Code | QCU |
| Premarket Review |
Office of In Vitro Diagnostics
(OHT7)
Division of Microbiology Devices
(DMD)
|
| Submission Type |
510(k)
|
| Regulation Number |
866.3945
|
| Device Class |
2
|
| Total Product Life Cycle (TPLC) |
TPLC Product Code Report
|
| GMP Exempt? |
No
|
Summary Malfunction Reporting |
Ineligible |
| Implanted Device? |
No
|
| Life-Sustain/Support Device? |
No
|
| Guidance Document
|
| Third Party Review |
Not Third Party Eligible |